Coco Kou

Direttore Finanziario/CFO presso QHY GROUP

43 anni

Consumer Services

Industrial Services

Finance

Profilo

Coco Kou is currently the Chief Financial Officer at QHY Group and the Chief Financial & Accounting Officer at Four Leaf Acquisition Corp.
Previously, Ms. Kou served as the Chief Financial Officer at Xynomic Pharmaceuticals Holdings, Inc. from 2019 to 2021 and at Salion Food Condiment Co., Ltd.
from 2017 to 2018.
Ms. Kou holds undergraduate and graduate degrees from Peking University, an MBA from the University of Hong Kong, London Business School, and Columbia Business School.

Posizioni attive di Coco Kou

Società	Posizione	Inizio
QHY GROUP	Direttore Finanziario/CFO	-
FOUR LEAF ACQUISITION CORPORATION	Direttore Finanziario/CFO	01/01/2022

Tutte le posizioni attive di Coco Kou

Precedenti posizioni note di Coco Kou

Società	Posizione	Fine
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.	Direttore Finanziario/CFO	01/01/2021
Salion Food Condiment Co., Ltd. Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China.	Direttore Finanziario/CFO	01/01/2018

Vedi nel dettaglio l'esperienza di Coco Kou

Formazione di Coco Kou

Peking University	Graduate Degree
Columbia Business School	Masters Business Admin
London Business School	Masters Business Admin
University of Hong Kong	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Coco Kou

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
QHY GROUP	Industrial Services
FOUR LEAF ACQUISITION CORPORATION	Finance

Aziende private	2
Xynomic Pharmaceuticals Holdings, Inc. Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China.	Health Technology
Salion Food Condiment Co., Ltd. Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China.	Consumer Non-Durables

Aziende private

Health Technology

Consumer Non-Durables

Vedi le connessioni aziendali